Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3961856

CCCC(CC)C(=O)O.Cl

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.75
CHRM3 known ✓ P20309 1/20 0.75
HTR2A known ✓ P28223 1/20 0.75
HTR2C known ✓ P28335 1/20 0.75
ADRA1A known ✓ P35348 1/20 0.75
HRH1 known ✓ P35367 1/20 0.75
DRD3 known ✓ P35462 1/20 0.75
SLC6A3 known ✓ Q01959 1/20 0.75
HDAC1 known ✓ Q13547 1/20 0.75
HDAC2 known ✓ Q92769 1/20 0.75
CA2 known ✓ P00918 4/20 0.70
HDAC7 known ✓ Q8WUI4 1/20 0.46
HDAC8 known ✓ Q9BY41 1/20 0.46
HDAC6 known ✓ Q9UBN7 1/20 0.46
HDAC9 known ✓ Q9UKV0 1/20 0.46
HDAC5 known ✓ Q9UQL6 1/20 0.46
AKR1A1 P14550 1/20 0.75
TDP1 Q9NUW8 1/20 0.75
MAPK1 P28482 1/20 0.70
SLC1A2 P43004 4/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL184958 0.97
SCHEMBL14666039 0.97
Ammonia Solution, Strong SCHEMBL28219690 0.95 CHRM1 (0.75) CHRM1AKR1A1CHRM3HTR2AHTR2C
Fluoride SCHEMBL28220995 0.95 CHRM1 (0.75) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL22396459 0.95 CHRM1 (0.75) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL3790981 0.95 CHRM1 (0.75) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL8412733 0.95 CHRM1 (0.75) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL28205518 0.90 CHRM1 (0.68) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL8723551 0.89 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL16684618 0.88 CA2 (0.75) CHRM1AKR1A1CHRM3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed
CN-111601798-B Bisamide sarcomere activating compounds and uses thereof 美国安进公司 2023-08-11 CN disclosed
CN-109803967-B Dihydropyrimidine compound and preparation method and application thereof 浙江海正药业股份有限公司 2022-05-24 CN disclosed
CN-111601798-A Bisamide sarcomere activating compound and use thereof 美国安进公司 2020-08-28 CN disclosed
CN-109803967-A Dihydropyrimidines and its preparation method and application 浙江海正药业股份有限公司 2019-05-24 CN disclosed
CN-106715418-A Therapeutic compounds and methods of use thereof 基因泰克公司 2017-05-24 CN disclosed
CN-103596933-B As dicyclo (3.1.0) hexane-2, the 6-dicarboxylic acid derivatives of MGLU2 receptor stimulant ELI LILLY AND CO. (US) 2016-03-23 CN disclosed
WO-2009037719-A1 NOVEL COMPOUNDS AS DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS LUPIN LIMITED (IN) 2009-03-26 WO disclosed
US-3934587-A Disposable articles having a water-permeable and water-repellent surface GORDON ROY GERALD 1976-01-27 US disclosed